CA2136008A1 - Substituted (arylalkylaminobenzyl)amino-propionamide derivatives and process for their preparation - Google Patents

Substituted (arylalkylaminobenzyl)amino-propionamide derivatives and process for their preparation

Info

Publication number
CA2136008A1
CA2136008A1 CA002136008A CA2136008A CA2136008A1 CA 2136008 A1 CA2136008 A1 CA 2136008A1 CA 002136008 A CA002136008 A CA 002136008A CA 2136008 A CA2136008 A CA 2136008A CA 2136008 A1 CA2136008 A1 CA 2136008A1
Authority
CA
Canada
Prior art keywords
hydrogen
halogen
arylalkylaminobenzyl
amino
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002136008A
Other languages
French (fr)
Other versions
CA2136008C (en
Inventor
Mario Varasi
Philippe Dostert
Paolo Pevarello
Alberto Bonsignori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Newron Pharmaceuticals SpA
Original Assignee
Mario Varasi
Philippe Dostert
Paolo Pevarello
Alberto Bonsignori
Farmitalia Carlo Erba S.R.L.
Pharmacia S.P.A.
Pharmacia & Upjohn S.P.A.
Newron Pharmaceuticals S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mario Varasi, Philippe Dostert, Paolo Pevarello, Alberto Bonsignori, Farmitalia Carlo Erba S.R.L., Pharmacia S.P.A., Pharmacia & Upjohn S.P.A., Newron Pharmaceuticals S.P.A. filed Critical Mario Varasi
Publication of CA2136008A1 publication Critical patent/CA2136008A1/en
Application granted granted Critical
Publication of CA2136008C publication Critical patent/CA2136008C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

The invention provides new compounds of formula (I) wherein o is an integer of 1 to 4; each of R and R1, which may be the same or different, is hydrogen, halogen, trifluoromethyl or C1-C4 alkoxy; R2 is hydrogen or C1-C4 alkyl;
and a pharmaceutically acceptable salt thereof;
and wherein when, at the same time, R is hydrogen, R1 is hydrogen or halogen and n is one, then R2 is other than hydrogen or methyl; and of formula (IA) wherein R3 is halogen, and a pharmaceutically acceptable salt thereof, which are active on the central nervous system (CNS) and can be used in therapy as anti-epileptics, anti-Parkinson, neuroprotective, antidepressant, anti-spastic anal hypnotic agents.
CA002136008A 1993-04-01 1994-03-15 Substituted (arylalkylaminobenzyl)amino-propionamide derivatives and process for their preparation Expired - Fee Related CA2136008C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939306899A GB9306899D0 (en) 1993-04-01 1993-04-01 Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
GB9306899.7 1993-04-01
PCT/EP1994/000825 WO1994022809A1 (en) 1993-04-01 1994-03-15 Substituted (arylalkylaminobenzyl)aminopropionamide derivatives, their preparation and use anti-epileptic, neuroprotective and antidepressant agents

Publications (2)

Publication Number Publication Date
CA2136008A1 true CA2136008A1 (en) 1994-10-13
CA2136008C CA2136008C (en) 2005-06-14

Family

ID=10733226

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002136008A Expired - Fee Related CA2136008C (en) 1993-04-01 1994-03-15 Substituted (arylalkylaminobenzyl)amino-propionamide derivatives and process for their preparation

Country Status (21)

Country Link
US (1) US5449692A (en)
EP (1) EP0648202B1 (en)
JP (1) JP3542600B2 (en)
KR (1) KR950701905A (en)
CN (1) CN1035939C (en)
AT (1) ATE152442T1 (en)
AU (1) AU667169B2 (en)
CA (1) CA2136008C (en)
DE (1) DE69402935T2 (en)
DK (1) DK0648202T3 (en)
ES (1) ES2104370T3 (en)
FI (1) FI945582A (en)
GB (1) GB9306899D0 (en)
GR (1) GR3024150T3 (en)
HU (1) HUT70944A (en)
IL (1) IL108970A0 (en)
NZ (1) NZ263183A (en)
PL (1) PL306538A1 (en)
RU (1) RU94046144A (en)
WO (1) WO1994022809A1 (en)
ZA (1) ZA941964B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9515412D0 (en) * 1995-07-27 1995-09-27 Pharmacia Spa 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
IT1283489B1 (en) * 1996-07-23 1998-04-21 Chiesi Farma Spa AMIDES OF ALPHA-AMINO ACIDS, THEIR PREPARATION AND THEIR THERAPEUTIC USE
ES2352739T3 (en) * 1997-11-21 2011-02-22 Purdue Neuroscience Company 2-SUBSTITUTED AMINO ACETAMIDS AND THE USE OF THE SAME.
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
US6281211B1 (en) 1999-02-04 2001-08-28 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
EP1169060B1 (en) * 1999-04-09 2005-08-31 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
JP4350508B2 (en) 2001-09-03 2009-10-21 ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー Pharmaceutical composition containing gabapentin or an analog thereof and α-aminoamide and analgesic use thereof
EP1438956A1 (en) 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
BRPI0515154A (en) * 2004-09-10 2008-07-08 Newron Pharm Spa use of (halobenzyloxy) benzylamino propanamides for the manufacture of active pharmaceuticals, compounds and pharmaceutical composition
RU2008120619A (en) * 2005-10-26 2009-12-10 БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) (HETERO) ARILS WITH ANTAGONISTIC ACTIVITY AGAINST MELANINE-CONCENTRATING HORMONE

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140748A (en) * 1966-06-23 1969-01-22 Ici Ltd New carboxylic acid derivatives
US4049663A (en) * 1972-06-06 1977-09-20 Allen & Hanburys Limited Ethylene diamine derivatives
DE3050800C2 (en) * 1979-03-22 1989-06-22 Continental Pharma Inc., Bruessel/Bruxelles, Be
FR2480747A1 (en) * 1980-04-17 1981-10-23 Roques Bernard AMINO ACID DERIVATIVES AND THEIR THERAPEUTIC APPLICATION
US4728668A (en) * 1985-04-16 1988-03-01 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4725619A (en) * 1985-04-16 1988-02-16 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical compositions containing n-phenylalkyl substituted alpha-amino carboxamide derivatives, some such novel compounds and their preparation

Also Published As

Publication number Publication date
AU6377694A (en) 1994-10-24
PL306538A1 (en) 1995-04-03
EP0648202B1 (en) 1997-05-02
EP0648202A1 (en) 1995-04-19
DE69402935D1 (en) 1997-06-05
HUT70944A (en) 1995-11-28
ES2104370T3 (en) 1997-10-01
KR950701905A (en) 1995-05-17
GB9306899D0 (en) 1993-05-26
US5449692A (en) 1995-09-12
ZA941964B (en) 1994-10-19
JPH08504828A (en) 1996-05-28
JP3542600B2 (en) 2004-07-14
CA2136008C (en) 2005-06-14
GR3024150T3 (en) 1997-10-31
HU9403809D0 (en) 1995-02-28
FI945582A0 (en) 1994-11-28
NZ263183A (en) 1996-02-27
DE69402935T2 (en) 1997-11-20
RU94046144A (en) 1996-09-27
IL108970A0 (en) 1994-06-24
AU667169B2 (en) 1996-03-07
CN1035939C (en) 1997-09-24
WO1994022809A1 (en) 1994-10-13
FI945582A (en) 1994-11-28
CN1104018A (en) 1995-06-21
DK0648202T3 (en) 1997-10-27
ATE152442T1 (en) 1997-05-15

Similar Documents

Publication Publication Date Title
ATE163012T1 (en) N-SUBSTITUTED 4-PYRIMIDINAMINES AND - PYRIMIDINDIAMINES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
CA2135783A1 (en) Substituted (arylalkoxybenzyl) amino-propanamide derivatives and process for their preparation
FI961914A (en) Short-acting dihydropyridines
NZ330973A (en) Azolobenzazepine derivatives as neurologically active agents
CA2136008A1 (en) Substituted (arylalkylaminobenzyl)amino-propionamide derivatives and process for their preparation
DE69330601T2 (en) SEROTON INERGIC ERGOLIN DERIVATIVES
CA2050875A1 (en) 3-(1h-indazol-3-yl)-4-pyridinamines, a process and intermediates for their preparation and their use as medicaments
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
IE812941L (en) Imidazole derivatives
IE802682L (en) Oxazoline derivatives
MX9802816A (en) Pyrimidin derivatives.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed